Clinical trial
Clinical and Therapeutic Evaluation of Meloxicam in Mexican Patients With Rheumatic Diseases
NCT02184065 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Therapeutic Evaluation of Meloxicam in Mexican Patients With Rheumatic Diseases
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- Not reported
- Enrollment
- 22,639 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.